News Center

Fucoidan: Not only does it inhibit inflammation at its source, it also protects organs!

Inflammation is like a "mini volcano" in the body; if it gets out of control, it can not only cause local discomfort but also trigger serious problems such as pneumonia and sepsis. Common anti-inflammatory drugs, however, can have side effects. A recent study published in *Marine Drugs* in 2024 discovered that fucoidan , extracted from a common brown seaweed species found along the Asian coast, is a natural anti-inflammatory agent. Oral administration can effectively inhibit lipopolysaccharide (LPS)-induced inflammation and protect organs such as the lungs and liver, providing a new option for natural anti-inflammatory treatments!

How terrible is uncontrolled inflammation? The root cause is actually the "overworking" of immune cells.

Inflammation is the body's self-protective response, but when pathogens invade and trigger excessive activation of immune cells, a "cytokine storm" can form: dendritic cells, macrophages and other immune cells release large amounts of pro-inflammatory factors such as IL-1β and TNF-α, which not only damage surrounding healthy tissues, but may also cause acute pneumonia, and in severe cases even induce sepsis, leading to liver and lung damage and endangering life.

Lipopolysaccharide (LPS, an endotoxin of Gram-negative bacteria) is a common culprit in triggering cytokine storms. Humans are 1000 to 10000 times more sensitive to it than mice, and it can easily induce a strong inflammatory response if not handled carefully. Fortunately, research has found that fucoidan derived from brown algae can precisely regulate immune cells, inhibiting the inflammatory response at its source.

Experimental evidence confirms the anti-inflammatory effects of fucoidan. Data provides further evidence.

The research team systematically verified the anti-inflammatory effects of fucoidan  through in vitro cell experiments and in mouse experiments, demonstrating progressive effects from the cellular level to organ protection. All data were statistically validated, and the results are convincing.

Step 1: Inhibiting Over-Activation of Immune Cells and Extinguishing the "Spark" of Inflammation. 

Dendritic cells are the "initiators" of the inflammatory response. LPS causes them to morphologically abnormal and their surface activation markers to surge, leading to the release of a large number of pro-inflammatory factors.

 ✅ After pretreatment with fucoidan, the LPS-induced morphological abnormalities of dendritic cells were significantly improved, and the over-branched activation state was no longer observed.

✅ The expression of surface activation markers such as CD40, CD80, and MHC decreased in a dose-dependent manner with increasing fucoidan concentration.

✅ The secretion of core pro-inflammatory factors was significantly reduced: the release of IL-1β, IL-6, IL-12, and TNF-α were all significantly decreased (p<0.01), preventing the amplification of inflammation at its source.

Step 2: Alleviating acute lung inflammation and reducing lung tissue damage. 

Mice were orally administered fucoidan for 3 consecutive days, followed by LPS-induced acute pneumonia. The results showed: 

✅ Significantly reduced lung inflammatory infiltration: The LPS group mice had a large number of leukocyte infiltrations in their lungs, while the fucoidan-treated group showed significantly reduced lung tissue damage and more intact structure.

✅ A sharp drop in the concentration of pro-inflammatory factors in bronchoalveolar lavage fluid: The levels of key factors such as IL-1β and IL-6 were significantly reduced, and the inflammatory response in the lungs was effectively controlled.

Step 3: Combating Sepsis, Protecting the Liver, and Improving Survival Rate. 

Sepsis is a severe consequence of cytokine storms. LPS-induced sepsis can lead to rapid death in mice and cause liver damage (elevated transaminases). Fucoidan, however, performed remarkably well: 

✅ Significantly improved survival rate: All mice in the pure LPS group died within 42 hours, while mice orally administered 100mg/kg fucoidan had a 50% survival rate, and the 50mg/kg group had a 40% survival rate.

✅ Protected liver function: LPS significantly increases serum ALT and AST (liver damage markers), while the fucoidan-treated group showed significant reductions in these two indicators, effectively reducing liver toxicity. 

✅ Significant systemic anti-inflammatory effect: Serum concentrations of pro-inflammatory factors such as IL-1β, IL-6, and TNF-α in mice decreased significantly, with anti-inflammatory effects comparable to the clinically used anti-inflammatory drug dexamethasone! 

Furthermore, oral administration of fucoidan alone had no adverse effects on healthy mice, did not induce inflammation or organ damage, and its safety was fully guaranteed.

Why is fucoidan so effective?

The fucoidan extracted from brown seaweed in this study possesses natural anti-inflammatory advantages in both its composition and properties, which is key to its outstanding efficacy.

1. Naturally extracted, ensuring purity: Extracted from brown seaweed using a water extraction process, with an extraction rate of 4.5±0.21% and a molecular weight of 420 kDa, it contains characteristic fucoidan components such as fucose, sulfate groups, and uronic acid. L-fucose content is 25.4%, and sulfate groups are 26.7%, forming the core structure for its anti-inflammatory effects.

2. Easily absorbed orally, with broad applicability: Unlike some anti-inflammatory substances that require injection, fucoidan can be taken orally directly and exerts a systemic anti-inflammatory effect, regulating both local inflammation and systemic cytokine storms.

3. Food and medicine homology, with extremely low side effects: Brown seaweed is a common edible seaweed along the Asian coast and a traditional Chinese medicine with a long history of daily consumption. The fucoidan extracted from it is highly compatible with the human body, far superior to the side effects of synthetic anti-inflammatory drugs.

Beyond its anti-inflammatory properties, fucoidan has shown great promise.

This natural fucoidan from the ocean not only precisely inhibits inflammatory responses but also protects vital organs such as the lungs and liver, preventing secondary damage caused by inflammation. More importantly, its oral efficacy and high safety mean it is no longer confined to the laboratory but possesses enormous potential for development into a natural health supplement.

For people who suffer from chronic inflammation or need to prevent inflammatory responses, fucoidan is a gentle and natural conditioning option; its performance in acute inflammations such as pneumonia and sepsis also provides a new direction for the clinical application of natural anti-inflammatory substances.

From marine algae to human anti-inflammatory agents, nature's gifts always bring surprises. Fucoidan, with solid experimental data, proves the anti-inflammatory power of natural marine substances, revealing the boundless possibilities of marine biological resources in the health field. This gentle anti-inflammatory power from the ocean is becoming a new option for protecting the body's inflammatory balance!

All experimental data and research conclusions in this article are derived from the authoritative paper "Anti-Inflammatory Effect of Fucoidan from Costaria costata Inhibited Lipopolysaccharide-Induced Inflammation in Mice" published in Marine Drugs in 2024, and are verifiable and based on evidence.